Our friends from the Private Equity Stakeholder Project are back to help us unpack what's at stake with the sale of Walgreens to private equity firm Sycamore Partners. Jim Baker, Executive Director of PESP joins us to get into Sycamore's track record and why that brings up concerns for their involvement in Walgreens. We also get into how Trump 2.0 has been responding to private equity and a few wins we have been seeing at the state level. It's an important episode of anyone who has ever needed to go to the pharmacy, so it's an important episode for basically everyone.    Follow PESP on Instagram here Subscribe to the Patreon here